Standard Biotools | FLDM - Cash And Equivalent


Standard Biotools reported $129.42M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Agilent USD 1.79B 254M Sep/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Bio-Rad Laboratories USD 529.8M 134M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Illumina USD 1.42B 368M Dec/2025
Myriad Genetics USD 145.4M 71M Sep/2025
Nikon Corporation JPY 164.74B 1.15B Jun/2025
Pacific Biosciences Of California USD 56.47M 1.66M Sep/2025
Revvity USD 919.86M 11.53M Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sony JPY 2.09T 588.6B Dec/2025
Standard Biotools USD 129.42M 29.2M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Waters USD 587.83M 128.71M Dec/2025